Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Mangoceuticals(MGRX) the Revenue is 68.76 K (-59.1%);the EBIT is -1.033 M (+79.99%);the EPS is -0.0938 (+82.7%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B59.10%
----
----
EBIT
-0.00B79.99%
----
----
EPS
-0.093882.70%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf